Changsatja, Supitchaya, Chayanis Kositamongkol, Lucksamon Thamlikitkul, Pochamana Phisalprapa, and Touchanun Komonpaisarn. 2025. “COST-EFFECTIVENESS ANALYSIS OF ADJUVANT OSIMERTINIB IN RESECTED EGFR-MUTATED EARLY-STAGE NON-SMALL CELL LUNG CANCER IN THAILAND”. Proceedings of the International Conference on Public Health 9 (1):45-67. https://doi.org/10.17501/24246735.2024.9105.